Respiratory disorders and hospitalization rates during the second RSV season in preterm infants who received palivizumab prophylaxis during their first RSV season.
Fanos V, Scarcella A, Puddu M, Gallini F, Tuminelli F, Bragetti P, Gallina MR, Quartulli L, Benincori N, Citro G, Via LD, Barera G, DI Luzio Paparatti U, Merolla R, Romano GV, Guida G, Silvestri M, Rossi GA.
Fanos V, et al. Among authors: merolla r.
J Chemother. 2009 Jun;21(3):302-10. doi: 10.1179/joc.2009.21.3.302.
J Chemother. 2009.
PMID: 19567351